目的探讨预防性抗菌治疗对重型病毒性肝炎患者自发性细菌性腹膜炎(sbp)的发生及疗效的影响。
Objective to explore the effect of preventive antibacterial treatment on spontaneous bacterial peritonitis (SBP) in the patients with severe hepatitis.
在101项研究报告中，有7062例患者有自发性细菌性腹膜炎，他们在1个月和12个月的平均死亡率分别是32.5%和66.2%。
As reported in 101 studies, 7062 patients had spontaneous bacterial peritonitis. Their one - and 12-month median mortality rates were 32.5% and 66.2%, respectively.
自发性细菌性腹膜炎（SBP），是肝硬化晚期患者一种严重的并发症，这被归因于肠道细菌的移位。
Spontaneous bacterial peritonitis (SBP), a severe complication in patients with advanced liver cirrhosis, has been attributed to bacterial translocation from the intestine.
因此我们假设自发性细菌性腹膜炎(sbp)的发病风险与与肝硬化患者携带有NOD2突变基因有关。
We hypothesized that the risk of acquiring SBP is increased in patients with cirrhosis carrying NOD2 variants.
对象和方法：选择本院收治的130例肝硬化自发性细菌性腹膜炎患者为研究对象。
Methods: 130 cases of hospitalized cirrhotic patients with SBP were collected. The patients were divided into improved group and deteriorated group.
对象和方法：选择本院收治的130例肝硬化自发性细菌性腹膜炎患者为研究对象。
Methods: 130 cases of hospitalized cirrhotic patients with SBP were collected. The patients were divided into improved group and deteriorated group.
应用推荐